SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 80 filers reported holding SYNERON MEDICAL LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $84,000 | +44.8% | 7,736 | +38.7% | 0.00% | +33.3% |
| Q1 2017 | $58,000 | -75.6% | 5,577 | -80.4% | 0.00% | -78.6% |
| Q4 2016 | $238,000 | +2544.4% | 28,398 | +2144.9% | 0.01% | +1300.0% |
| Q3 2016 | $9,000 | +80.0% | 1,265 | +75.7% | 0.00% | – |
| Q2 2016 | $5,000 | – | 720 | +958.8% | 0.00% | – |
| Q2 2015 | $0 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 2,738 | $30,000 | 90.91% |
| BRANDES INVESTMENT PARTNERS, LP | 2,901,971 | $31,921,000 | 0.65% |
| Lapides Asset Management, LLC | 186,200 | $2,044,000 | 0.42% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 51,703 | $569,000 | 0.04% |